The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 338:1461-1463 May 14, 1998 Number 20
NextNext

Epstein–Barr Virus in Action in Vivo

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Liebowitz, D.
-PubMed Citation
Epstein–Barr virus (EBV), a B-lymphotropic herpesvirus carried by almost everyone as a lifelong asymptomatic infection, is implicated in the pathogenesis of at least three malignant disorders of B cells.1 One is Burkitt's lymphoma, which in its endemic form in equatorial Africa almost always contains the virus. A rare sporadic form of Burkitt's lymphoma that occurs in Western countries contains the virus in 10 to 20 percent of cases. The second B-cell tumor linked to EBV is classic Hodgkin's disease,2 which is associated with the virus in 40 percent of the cases in the West and in more than 80 percent . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.